| Literature DB >> 33432656 |
Mark H Johnson1,2, Tony Charman3, Andrew Pickles4, Emily J H Jones1.
Abstract
We present the Anterior Modifiers in the Emergence of Neurodevelopmental Disorders (AMEND) framework, designed to reframe the field of prospective studies of neurodevelopmental disorders. In AMEND we propose conceptual, statistical and methodological approaches to separating markers of early-stage perturbations from later developmental modifiers. We describe the evidence for, and features of, these interacting components before outlining analytical approaches to studying how different profiles of early perturbations and later modifiers interact to produce phenotypic outcomes. We suggest this approach could both advance our theoretical understanding and clinical approach to the emergence of developmental psychopathology in early childhood.Entities:
Keywords: Neurodevelopmental disorders; autism spectrum disorders; brain development
Mesh:
Year: 2021 PMID: 33432656 PMCID: PMC8609429 DOI: 10.1111/jcpp.13372
Source DB: PubMed Journal: J Child Psychol Psychiatry ISSN: 0021-9630 Impact factor: 8.982
Consideration of the relation between our framework and the concepts of risk and protective factors in psychiatry
| Concept | Definition and relation to AMEND |
|---|---|
| Early‐stage Processing (ESP) | Markers that reflect the activity of brain systems engaged in sensory and motor functions in early development; without moderation by neurocognitive modifiers atypical early‐stage processing leads to atypical phenotypic outcomes; in this sense, atypical early‐stage processing can be a |
| Neurocognitive modifier system (NMS) | Trajectory‐modifying brain systems associated with anterior regions of cortex; they moderate the association between ESP and phenotypic outcome such that strong NMS activity pushes trajectories towards typical outcome; as these systems act in parallel and/or later than atypical ESP they constitute |
| Risk/Risk factor | ‘Risk factors’ are typically defined as variables associated with an increased risk of later disease; in turn, ‘risk’ itself is often defined as the degree of probability of loss, injury, peril or hazard. Two elements of these definitions can be problematic in the context of developing a mechanistic understanding of neurodevelopmental disorders: (a) the term ‘risk’ implies relation to a negative outcome, and as such implies an inappropriate value judgement about autism and ADHD; (b) risk factors are defined by their probabilistic relation to a particular outcome, which while useful in a clinical context, is less helpful for mechanistic accounts of developmental trajectories. In AMEND, atypical ESP factors at a given age statistically associate with later phenotypic status and thus represent risk markers. However, this risk is reduced by the degree of action of NMS. |
| Resilience/ Protective factors |
|
Figure 1Illustration of the analysis steps motivated by the AMEND framework. Arrows A1 to A3 are described in the text. Colour green indicates the influence of initial factors and Early Stage Processing, while blue indicates the influence of Neurocognitive modifiers. Phenotypic outcomes are represented on the right hand side as resulting from a combination of these factors
Figure 2Illustration of a random‐intercept cross‐lagged model to examine how executive attention might over time (through the red paths), reduce the magnitude of (purple) paths that reflect the cumulative impact of an early‐stage marker on later phenotypic outcome